This post is from a suggested group
Breast Lesion Guidance Systems Market – Industry Trends and Forecast to 2029
Introduction
The Breast Lesion Guidance Systems Market refers to medical devices and technologies used to locate, mark, and guide the removal or biopsy of lesions in breast tissue. These systems are vital where lesions are non-palpable, difficult to find externally, or where precise guidance improves surgical or diagnostic outcomes.
The market holds critical importance globally. Breast cancer remains one of the most commonly diagnosed cancers among women. Early detection and precise localization of suspicious lesions are key to improving prognosis, reducing invasive surgery, and lowering treatment costs. The growth in screening programs, imaging modalities (MRI, ultrasound, mammography including tomosynthesis), and increasing awareness drive demand for guidance systems worldwide.
Current size of the market is evolving. For example, the breast lesion localization methods market was valued at about USD 2.46 billion in 2025 and is forecast to reach USD 3.78 billion by 2030, growing at a CAGR of approximately 8.97%. Mordor Intelligence

